Roberto Guerciolini
Plus aucun poste en cours
Historique de carrière de Roberto Guerciolini
Anciens postes connus de Roberto Guerciolini
Sociétés | Poste | Début | Fin |
---|---|---|---|
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | 12/02/2019 | 05/10/2020 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/04/2004 | 01/10/2006 |
WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | - | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
American Board of Clinical Pharmacology, Inc.
American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services American Board of Clinical Pharmacology, Inc. operates as health-related professional association. It provides evaluation for training credentials, preparation and administration for examinations, and register and accredit training programs in clinical pharmacology. in The company is headquartered in San Antonio, TX. | Corporate Officer/Principal | - | - |
DICERNA PHARMACEUTICALS, INC. | Fondateur | 10/08/2009 | - |
Corporate Officer/Principal | 01/01/2007 | - |
Formation de Roberto Guerciolini
University of California, Berkeley | Masters Business Admin |
University of Perugia | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Italie | 2 |
Singapour | 2 |
Opérationnelle
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 2 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 7 |
Commercial Services | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
WAVE LIFE SCIENCES LTD. | Health Technology |
Entreprise privées | 7 |
---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
American Board of Clinical Pharmacology, Inc.
American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services American Board of Clinical Pharmacology, Inc. operates as health-related professional association. It provides evaluation for training credentials, preparation and administration for examinations, and register and accredit training programs in clinical pharmacology. in The company is headquartered in San Antonio, TX. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Roberto Guerciolini
- Expérience